20 May 2021
Healthcare supply chains are becoming increasingly complex due to rapidly evolving product regulations and requirements from both original equipment manufacturers and their downstream end users such as patients and healthcare professionals. As a result, companies along the healthcare supply chain are looking for ways to adapt by acquiring new capabilities that will enable them to expand into new applications and/or respond to customer needs. This dynamic is generating significant opportunities to create value through strategic acquisitions.
In a joint report, Macquarie Capital and L.E.K. Consulting examine the trends driving investor appetite in Healthcare Components and Solutions (HCCS) – a portion of the market that appears ripe for investment and M&A activity. HCCS includes:
Compared to the consumer space, there are a number of distinguishing characteristics that support higher valuations for HCCS companies. With an understanding of the sector, there are multiple avenues to build a HCCS platform and create value through M&A.
For more information on investment and M&A opportunities in the healthcare components and solutions space, please download the report from Macquarie Capital and L.E.K. Consulting below or reach out to one of our specialists.
Senior Managing Director and Co-Head of Macquarie Capital’s Industrials business in the Americas
Senior Vice President, Macquarie Capital
Associate, Macquarie Capital